ENOV
Overvalued by 174.6% based on the discounted cash flow analysis.
Market cap | $2.27 Billion |
---|---|
Enterprise Value | $2.38 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $-0.61 |
Beta | 2.01 |
Outstanding Shares | 54,855,810 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -24.65 |
---|---|
PEG | -2.48 |
Price to Sales | 0.92 |
Price to Book Ratio | 0.72 |
Enterprise Value to Revenue | 1.19 |
Enterprise Value to EBIT | -20.71 |
Enterprise Value to Net Income | -20 |
Total Debt to Enterprise | 0.06 |
Debt to Equity | 0.06 |
No data
No data
Colfax Corporation is a leading diversified technology company that provides specialty medical technologies and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax...